文献速递免疫规划传染病防控与疫情报告

肺炎球菌结合疫苗时代儿童急性中耳炎发病率与细菌病原学的系统综述与荟萃分析

Incidence and bacterial etiology of acute otitis media in children in the pneumococcal conjugate vaccine era: A systematic literature review and meta-analysis.
PubMed 文献 · Vaccine · 2026-01-29

该系统综述与荟萃分析评估了肺炎球菌结合疫苗(PCV)时代儿童急性中耳炎(AOM)的发病率和细菌病原学分布。研究纳入37篇发病率文献(25篇进入荟萃分析)和34篇中耳液病原学文献,发现≤2岁儿童AOM发病率最高(18.77/100人年),且未接种PCV者发病率(34.26/100人年)高于接种者(16.07/100人年);≤2岁儿童中,流感嗜血杆菌(Hi)占31.81%,肺炎链球菌(Spn)占19.35%,卡他莫拉菌(Mcat)占3.00%。

要点

  • ≤2岁儿童AOM发病率最高,未接种PCV者发病率高于接种者。
  • ≤2岁AOM病例中Hi占比最高(31.81%),其次为Spn(19.35%)。
  • Hi-AOM中78.2%由不可分型流感嗜血杆菌(NTHi)引起。

核心结论

  • PCV时代儿童AOM负担仍然显著,≤2岁儿童发病率尤其高。
  • 部分PCV血清型、非PCV血清型及NTHi对AOM负担有重要贡献。
  • 需要能提供更好保护覆盖剩余PCV血清型、新出现肺炎球菌血清型及NTHi的疫苗。

研究设计与样本

  • 系统文献综述与荟萃分析,检索Embase、MEDLINE、LILACS和SciELO数据库。
  • 发病率文献发表时间为2008-2023年,病原学文献发表时间为2010-2023年。
  • 纳入37篇发病率文献(25篇进入荟萃分析)和34篇中耳液病原学文献。
  • 采用随机效应模型计算合并发病率、合并病原体患病率及95%CI,按年龄、地区和PCV接种状态分层,用I2评估异质性。

主要发现

  • AOM发病率(每100人年):≤2岁为18.77,>2至≤5岁为10.39,>5岁低于3。
  • ≤2岁儿童中,接种PCV者AOM发病率为16.07/100人年,未接种者为34.26/100人年。
  • ≤2岁儿童AOM病例中,Hi占31.81%,Spn占19.35%,Mcat占3.00%。
  • Spn-AOM中常见血清型为3(10.81%)、19F(10.65%)、19A(10.43%)、23A(4.60%)、35B(4.38%)和21(3.23%)。
  • Hi-AOM病例中78.2%由NTHi引起。

临床怎么用

  • 在≤2岁儿童AOM防控中,应关注PCV接种对降低发病率的潜在作用。
  • 临床中需考虑NTHi和特定肺炎球菌血清型在AOM病原学中的持续贡献。
  • 疫苗研发和接种策略可参考本研究中残余血清型和NTHi的分布数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: This systematic literature review (SLR) evaluated the incidence and bacterial etiology of acute otitis media (AOM) in children. METHODS: Epidemiological studies in English reporting on AOM incidence (published 2008-2023) or the distribution of Streptococcus pneumoniae (Spn) including serotypes, Haemophilus influenzae (Hi), and Moraxella catarrhalis (Mcat) in children (<18 years) with AOM (published 2010-2023) were identified from Embase, MEDLINE, LILACS, and SciELO databases. Random-effect models were used to determine the pooled AOM incidence rates (IR), pooled prevalence of each bacterium and individual serotypes/strains, and the corresponding 95% confidence intervals. When feasible, the estimates were stratified by age group, geographical location, and pneumococcal vaccination status. Heterogeneity was assessed by the I2 statistic. FINDINGS: The SLR identified 37 publications reporting on AOM incidence, of which 25 were included in the meta-analysis, and 34 publications reporting on prevalence of bacterial pathogens in middle ear fluid. AOM IRs (per 100 person-years) were 18.77 in ≤2-year-olds, 10.39 in >2 to ≤5-year-olds, and <3 in children aged >5 years. In ≤2-year-olds, AOM IR was 16.07 among those who received a pneumococcal conjugate vaccine (PCV) and 34.26 among those who did not. Among ≤2-year-olds, Hi contributed to 31.81% of AOM cases, followed by 19.35% for Spn, and 3.00% for Mcat. Across all ages, frequently reported Spn serotypes among Spn-AOM cases were 3 (10.81%), 19F (10.65%), 19A (10.43%), 23A (4.60%), 35B (4.38%), and 21 (3.23%) whereas 78.2% of Hi-AOM cases were caused by non-typeable Hi (NTHi). INTERPRETATION: A substantial AOM burden in children remains during the PCV era, with disproportionately higher incidence among children ≤2 years old. Select PCV- and non-PCV pneumococcal serotypes and NTHi have contributed significantly to the AOM burden. Vaccines offering improved protection against remaining PCV serotypes, emerging pneumococcal serotypes, and NTHi are needed to reduce the existing AOM burden in children.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Bhuiyan MU, Hernandez-Suarez G, Pilishvili T, et al. Incidence and bacterial etiology of acute otitis media in children in the pneumococcal conjugate vaccine era: A systematic literature review and meta-analysis. Vaccine. 2026. PMID: 41616651. doi:10.1016/j.vaccine.2026.128270

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。